Pinned straw:
Just had a closer look this morning at investing activities.
One issue I do have is the breakdown on property, plant and equipment
Versus increase in deployed units
Previous quarter
Versus additional deployments
In conclusion if I assume purchase of property/plant/equipment is related to number of deployed units then it seems that the deployment cost is going up per unit (from 4.6m per unit to 6m per unit) and not staying constant
Then again I could be wrong and this is a question I submitted.
@edgescape the 4C says that "Chrysos completed factory acceptance testing of an additional three new units, creating a total of 14 PhotonAssayTM units that are now ready to be shipped and installed in support of Chrysos’ FY25 deployment schedule.".
Upfront costs would have incurred to get these units to ready-for-deployment stage. So do not believe that the cash expense is directly related to units deployed alone.
But its a good question to ask.
I am wanting to peel the reasons for the slowing in deployment momentum and when should we expect that this momentum picks up again.